Literature DB >> 24292710

Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life.

Paul R Hess, David R Rawnsley, Zoltán Jakus, Yiqing Yang, Daniel T Sweet, Jianxin Fu, Brett Herzog, MinMin Lu, Bernhard Nieswandt, Guillermo Oliver, Taija Makinen, Lijun Xia, Mark L Kahn.   

Abstract

Mammals transport blood through a high-pressure, closed vascular network and lymph through a low-pressure, open vascular network. These vascular networks connect at the lymphovenous (LV) junction, where lymph drains into blood and an LV valve (LVV) prevents backflow of blood into lymphatic vessels. Here we describe an essential role for platelets in preventing blood from entering the lymphatic system at the LV junction. Loss of CLEC2, a receptor that activates platelets in response to lymphatic endothelial cells, resulted in backfilling of the lymphatic network with blood from the thoracic duct (TD) in both neonatal and mature mice. Fibrin-containing platelet thrombi were observed at the LVV and in the terminal TD in wild-type mice, but not Clec2-deficient mice. Analysis of mice lacking LVVs or lymphatic valves revealed that platelet-mediated thrombus formation limits LV backflow under conditions of impaired valve function. Examination of mice lacking integrin-mediated platelet aggregation indicated that platelet aggregation stabilizes thrombi that form in the lymphatic vascular environment to prevent retrograde blood flow. Collectively, these studies unveil a newly recognized form of hemostasis that functions with the LVV to safeguard the lymphatic vascular network throughout life.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24292710      PMCID: PMC3871239          DOI: 10.1172/JCI70422

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

Review 1.  The growing complexity of platelet aggregation.

Authors:  Shaun P Jackson
Journal:  Blood       Date:  2007-02-20       Impact factor: 22.113

2.  Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor.

Authors:  Polly R Pine; Betty Chang; Nathan Schoettler; Mona L Banquerigo; Su Wang; Angela Lau; Feifei Zhao; Elliott B Grossbard; Donald G Payan; Ernest Brahn
Journal:  Clin Immunol       Date:  2007-05-29       Impact factor: 3.969

Review 3.  Platelet activation and atherothrombosis.

Authors:  Giovanni Davì; Carlo Patrono
Journal:  N Engl J Med       Date:  2007-12-13       Impact factor: 91.245

4.  Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target.

Authors:  Ryan M Young; Ian R Hardy; Raedun L Clarke; Nicolai Lundy; Polly Pine; Brian C Turner; Terry A Potter; Yosef Refaeli
Journal:  Blood       Date:  2008-11-03       Impact factor: 22.113

5.  Terminal part of thoracic duct: high-resolution US imaging.

Authors:  Marcus Seeger; Burkhard Bewig; Rainer Günther; Clemens Schafmayer; Bernd Vollnberg; Diana Rubin; Christine Hoell; Stefan Schreiber; Ulrich R Fölsch; Jochen Hampe
Journal:  Radiology       Date:  2009-07-31       Impact factor: 11.105

6.  CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis.

Authors:  Frauke May; Ina Hagedorn; Irina Pleines; Markus Bender; Timo Vögtle; Johannes Eble; Margitta Elvers; Bernhard Nieswandt
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

7.  Endothelial cell O-glycan deficiency causes blood/lymphatic misconnections and consequent fatty liver disease in mice.

Authors:  Jianxin Fu; Holger Gerhardt; J Michael McDaniel; Baoyun Xia; Xiaowei Liu; Lacramioara Ivanciu; Annelii Ny; Karlien Hermans; Robert Silasi-Mansat; Samuel McGee; Emma Nye; Tongzhong Ju; Maria I Ramirez; Peter Carmeliet; Richard D Cummings; Florea Lupu; Lijun Xia
Journal:  J Clin Invest       Date:  2008-10-16       Impact factor: 14.808

8.  A shear gradient-dependent platelet aggregation mechanism drives thrombus formation.

Authors:  Warwick S Nesbitt; Erik Westein; Francisco Javier Tovar-Lopez; Elham Tolouei; Arnan Mitchell; Jia Fu; Josie Carberry; Andreas Fouras; Shaun P Jackson
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

9.  Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice.

Authors:  Eleni Bazigou; Oliver T A Lyons; Alberto Smith; Graham E Venn; Celia Cope; Nigel A Brown; Taija Makinen
Journal:  J Clin Invest       Date:  2011-07-18       Impact factor: 14.808

10.  Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis.

Authors:  Eleni Bazigou; Sherry Xie; Chun Chen; Anne Weston; Naoyuki Miura; Lydia Sorokin; Ralf Adams; Andrés F Muro; Dean Sheppard; Taija Makinen
Journal:  Dev Cell       Date:  2009-08       Impact factor: 12.270

View more
  90 in total

1.  Lymphatic vessel development: fluid flow and valve-forming cells.

Authors:  Tsutomu Kume
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

Review 2.  Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets.

Authors:  Xiuli Sim; Mortimer Poncz; Paul Gadue; Deborah L French
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

3.  Platelet factor 4 is a biomarker for lymphatic-promoted disorders.

Authors:  Wanshu Ma; Hyea Jin Gil; Noelia Escobedo; Alberto Benito-Martín; Pilar Ximénez-Embún; Javier Muñoz; Héctor Peinado; Stanley G Rockson; Guillermo Oliver
Journal:  JCI Insight       Date:  2020-07-09

4.  Podoplanin and CLEC-2 drive cerebrovascular patterning and integrity during development.

Authors:  Kate L Lowe; Brenda A Finney; Carsten Deppermann; René Hägerling; Salomé L Gazit; Jon Frampton; Christopher Buckley; Eric Camerer; Bernhard Nieswandt; Friedemann Kiefer; Steve P Watson
Journal:  Blood       Date:  2015-04-23       Impact factor: 22.113

5.  Gq pathway regulates proximal C-type lectin-like receptor-2 (CLEC-2) signaling in platelets.

Authors:  Rachit Badolia; Vaishali Inamdar; Bhanu Kanth Manne; Carol Dangelmaier; Johannes A Eble; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2017-07-13       Impact factor: 5.157

6.  Distinct pathways regulate Syk protein activation downstream of immune tyrosine activation motif (ITAM) and hemITAM receptors in platelets.

Authors:  Bhanu Kanth Manne; Rachit Badolia; Carol Dangelmaier; Johannes A Eble; Wilfried Ellmeier; Mark Kahn; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

Review 7.  New Concepts and Mechanisms of Platelet Activation Signaling.

Authors:  Brian Estevez; Xiaoping Du
Journal:  Physiology (Bethesda)       Date:  2017-03

Review 8.  Amicus or Adversary Revisited: Platelets in Acute Lung Injury and Acute Respiratory Distress Syndrome.

Authors:  Elizabeth A Middleton; Matthew T Rondina; Hansjorg Schwertz; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

9.  Small GTPase Rap1A/B Is Required for Lymphatic Development and Adrenomedullin-Induced Stabilization of Lymphatic Endothelial Junctions.

Authors:  Wenjing Xu; Erika S Wittchen; Samantha L Hoopes; Lucia Stefanini; Keith Burridge; Kathleen M Caron
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

10.  Endogenous Specialized Proresolving Mediator Profiles in a Novel Experimental Model of Lymphatic Obstruction and Intestinal Inflammation in African Green Monkeys.

Authors:  Felix Becker; Emily Romero; Jason Goetzmann; Dana L Hasselschwert; Beth Dray; John Vanchiere; Jane Fontenot; J Winny Yun; Paul C Norris; Luke White; Melany Musso; Charles N Serhan; J Steven Alexander; Felicity N E Gavins
Journal:  Am J Pathol       Date:  2019-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.